Are you an adult diagnosed with multiple myeloma within the last 5 years? If so, you may be able to participate in our research study to help improve how myeloma is diagnosed. Tell us about your experience, what went well, and what didn't, so we can make things better for future myeloma patients. Your voice matters! Compensation will be provided.

Do you identify as Black or African-American? Have you been diagnosed with colon cancer, rectal cancer, or colorectal cancer? If so, you may be able to take part in a study to see if an exercise program can help with cancer side effects and overall quality of life. Compensation provided,

Do you have bladder cancer and have had your bladder removed? If so, you may be able to take part in a research study to determine if patients need additional treatment called immunotherapy to prevent cancer from coming back.

Have you been diagnosed with Blood Cancer. If so, you may be able to take part in a research study looking at the safety of giving a new drug called AK117 to patients with Leukemia

Are you at least 25 years old? Have you ever been referred for a colposcopy and had routine cervical cancer screening with HPV testing? If so, you may be able to take part in a study on newer ways to test for cervical cancer! We want to see if collecting vaginal samples on your own will give us the same results as when a doctor collects a cervical sample. Compensation provided.

Have you been diagnosed with an advanced B-cell malignancy, such as Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL), Mantle Cell Lymphoma (MCL), Follicular Lymphoma (FL), non-GCB Diffuse Large B-Cell Lymphoma (DLBCL), Marginal Zone Lymphoma (MZL) or Waldenstrom Macroglobulinemia (WM) and have either had your disease relapse or not respond to treatment? If so, you may be eligible for a trial utilizing an investigational oral drug to treat your cancer.

Have you been diagnosed with a cancer called Chronic Lymphocytic Leukemia (CLL)? . If so, you may be able to take part in a research study looking at the effectiveness of combination treatments of the drugs (sonrotoclax + Zanubrutinib) or (venetoclax + Obinutuzumab) for patients with Chronic Lymphocytic Leukemia (CLL) .

Have you been diagnosed with breast cancer and completed your surgery? Has your doctor recommended hormonal therapy to help prevent your cancer from returning? You may be able to participate in a research study of a new drug called Camizestrant. Please reach out to the research team if you are interested and we will provide information regarding the next steps.

Do you have ovarian, peritoneal, or fallopian tube cancer that came back after receiving standard therapy? If so, you might be able to take part in a study that looks at a new treatment, iC9.CAR.B7-H3 cells, to test the safety of these cells and observe any side effects.

This study is for patients diagnosed with breast cancer that has spread to other parts of the body, which is called Metastatic Breast Cancer. This study will look at information from your tumor that may help choose treatments. Researchers will use this information to find out how different patients may respond to different treatments, leading to better treatments for future patients. You may not benefit personally, but your doctor may be given information which may help guide your treatments.